Combimatrix Molecular Diagnostics

Combimatrix Molecular Diagnostics (CMDX) is engaged in the development and marketing of genetic test reagents for the in-vitro diagnostic markets. The company is a wholly owned subsidiary of CombiMatrix Corporation. Its HerScan test is the Bacterial Artificial Chromosome (BAC) Comparative Genomic Hybridization (CGH) array-based test for breast cancer. CMDX develops DNA-Based diagnostic products through its patented CustomArray technology. Its diagnostic products are utilized in the treatment of cancer. The products offering of the company are sold under the brand name of HerScan. It operates through three business units namely Diagnostic Testing Services, Clinical Trials and Manufacturing. CMDX is headquartered at California, the US.

Street: 
310 Goddard
City: 
Irvine
Postcode: 
92618
Federal State : 
United States
WebSite: 
www.cmdiagnostics.com
Fax: 
1-949-7531504

Company Index Score

Current Index Score Historical Index Score
  • Combimatrix Molecular Diagnostics currently scores 50 % in the index.
  • Combimatrix Molecular Diagnostics is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Combimatrix Molecular Diagnostics is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets